310 related articles for article (PubMed ID: 8468460)
21. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line.
Stoeck M; Miescher S; MacDonald HR; Von Fliedner V
J Cell Physiol; 1989 Oct; 141(1):65-73. PubMed ID: 2789227
[TBL] [Abstract][Full Text] [Related]
23. MHC class II molecules deliver costimulatory signals in human T cells through a functional linkage with IL-2-receptors.
Odum N; Kanner SB; Ledbetter JA; Svejgaard A
J Immunol; 1993 Jun; 150(12):5289-98. PubMed ID: 8515060
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
[TBL] [Abstract][Full Text] [Related]
25. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1.
Cerwenka A; Kovar H; Majdic O; Holter W
J Immunol; 1996 Jan; 156(2):459-64. PubMed ID: 8543794
[TBL] [Abstract][Full Text] [Related]
26. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
27. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
28. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms.
Fox FE; Ford HC; Douglas R; Cherian S; Nowell PC
Cell Immunol; 1993 Aug; 150(1):45-58. PubMed ID: 8393732
[TBL] [Abstract][Full Text] [Related]
29. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.
Pimentel-Muiños FX; Muñoz-Fernández MA; Fresno M
J Immunol; 1994 Jun; 152(12):5714-22. PubMed ID: 8207202
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
31. Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression.
Höllsberg P; Ausubel LJ; Hafler DA
J Immunol; 1994 Jul; 153(2):566-73. PubMed ID: 8021495
[TBL] [Abstract][Full Text] [Related]
32. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
33. Suppressor T cell-activating macrophages in ultraviolet-irradiated human skin induce a novel, TGF-beta-dependent form of T cell activation characterized by deficient IL-2r alpha expression.
Stevens SR; Shibaki A; Meunier L; Cooper KD
J Immunol; 1995 Dec; 155(12):5601-7. PubMed ID: 7499843
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2.
Stoeck M; Ruegg C; Miescher S; Carrel S; Cox D; Von Fliedner V; Alkan S
J Immunol; 1989 Nov; 143(10):3258-65. PubMed ID: 2530275
[TBL] [Abstract][Full Text] [Related]
35. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
36. Urokinase receptor. An activation antigen in human T lymphocytes.
Nykjaer A; Møller B; Todd RF; Christensen T; Andreasen PA; Gliemann J; Petersen CM
J Immunol; 1994 Jan; 152(2):505-16. PubMed ID: 8283034
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor type beta 1 (TGF-beta 1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line.
D'Angeac AD; Dornand J; Emonds-Alt X; Jullien P; Garcia-Sanz JA; Erard F
J Cell Physiol; 1991 Jun; 147(3):460-9. PubMed ID: 2066366
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.
Hackett RJ; Davis LS; Lipsky PE
J Immunol; 1988 Apr; 140(8):2639-44. PubMed ID: 2965728
[TBL] [Abstract][Full Text] [Related]
39. Early immune response and regulation of IL-2 receptor subunits.
Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
[TBL] [Abstract][Full Text] [Related]
40. Costimulation of cAMP and protein kinase C pathways inhibits the CD3-dependent T cell activation and leads to a persistent expression of the AP-1 transcription factor.
Rincón M; Tugores A; de Landázuri MO; López-Botet M
Cell Immunol; 1993 Jul; 149(2):343-56. PubMed ID: 8392437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
